Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden

Cancer Cell(2023)10.1016/j.ccell.2023.09.006Source: DataRank Database

Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 60 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access60 citations

Download PDF

Cite:

Linked data & code

gen refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 6.98)OA: bronzeTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Jiwoong Kim ORCID,Qing Deng ORCID,Biagio Ricciuti ORCID,Joao V. Alessi ORCID,Buse Eglenen-Polat

Live enrichment

PubMed:37774698 PMC:PMC10693909 OpenAlex:https://openalex.org/W4387131703

Welch Foundation

Grant: 1975-20190330

National Institutes of Health

Grant: R01CA237405

National Institutes of Health

Grant: R01CA265884

National Institutes of Health

Grant: RP180770

National Institutes of Health

Grant: RP210099

U.S. Department of Defense

Grant: W81XWH-21-1-0856

Cancer Prevention and Research Institute of Texas

Grant: RR160080

American Cancer Society

Grant: RSG-22-051-01-IBCD

National Cancer Institute

Grant: 5P50CA070907

National Cancer Institute

Grant: R01CA276058

National Comprehensive Cancer Network Foundation

Grant: NCCN 2021

NCI NIH HHS

Grant: P30 CA142543

NCI NIH HHS

Grant: P50 CA070907

A Breath of Hope Lung Foundation

AstraZeneca

Mary Kay Ash Foundation

FWCI

6.98

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610823003227/pdf

publisherhttp://www.cell.com/article/S1535610823003227/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610823003227?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823003227?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2023.09.006

Fields of Study

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsFerroptosis and cancer prognosisMiceAnimalsHumansLung NeoplasmsProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53Carcinoma, Non-Small-Cell LungMutation

MeSH Terms

AnimalsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsMutationTumor Suppressor Protein p53Proto-Oncogene Proteins p21(ras)Mice

Keywords

BiologyImmune systemCancer researchLung cancerMutationCancerImmunologyGeneticsTumor heterogeneityGeneMedicineOncologyMiceTMBHeterogeneityImmunotherapyAntigen presentationClonalityKrasTp53Patient SurvivalGemm

Sustainable Development Goals

SDG 0: Good health and well-being

Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden

FAIR Checklist

Authors (17)

Funding (16 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)